Dr. Nichols is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
161 Fort Washington Ave
New York, NY 10032Phone+1 212-305-5705
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1986 - 1990
University of ChicagoResidency, Internal Medicine, 1983 - 1986
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1983
Certifications & Licensure
NY State Medical License 1986 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia Start of enrollment: 1996 Feb 01
- G-CSF in Stimulating Peripheral Stem Cells for Autologous Stem Cell Transplant in Treating Patients With Chronic Phase Chronic Myeloid Leukemia in Complete Remission Start of enrollment: 2005 Jan 01
- Collecting Stem Cells in Patients With Waldenstrom's Macroglobulinemia Start of enrollment: 2005 Nov 01
Publications & Presentations
PubMed
- 437 citationsEffect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-m...Isabelle Ray-Coquard, Jean-Yves Blay, Antoine Italiano, Axel Le Cesne, Nicolas Penel
The Lancet. Oncology. 2012-11-01 - 241 citationsResults of the phase i trial of RG7112, a small-molecule MDM2 antagonist in leukemiaMichael Andreeff, Kevin R. Kelly, Karen W.L. Yee, Sarit Assouline, Roger Strair
Clinical Cancer Research. 2016-02-15 - 76 citationsAnti-spike antibody response to SARS-CoV-2 booster vaccination in patients with B cell-derived hematologic malignancies.Lee M. Greenberger, Larry A. Saltzman, Jonathon W. Senefeld, Patrick W. Johnson, Louis J. DeGennaro
Cancer Cell. 2021-10-11
Press Mentions
This 9-Year-Old's Cancer Was Treatable. But the Drugs Were Hard to Find.October 17th, 2024- Drug Revumenib Achieves Complete Cancer Remission in 18 People with LeukemiaMarch 21st, 2023
- World Renowned Childhood Blood Cancer Expert Named as the Leukemia & Lymphoma Society's New President and CEOMarch 8th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
